These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 4889754

  • 21. [A double-blind comparison between mianserin and imipramine (author's transl)].
    Pull CB, Pichot P, Dreyfus JF.
    Acta Psychiatr Belg; 1978; 78(5):827-32. PubMed ID: 375686
    [Abstract] [Full Text] [Related]

  • 22. The endogenous--neurotic distinction as a predictor of response to antidepressant drugs.
    Raskin A, Crook TH.
    Psychol Med; 1976 Feb; 6(1):59-70. PubMed ID: 935298
    [Abstract] [Full Text] [Related]

  • 23. Clomipramine HCL--a double-blind study of a new antidepressant drug.
    McClure DJ, Low GL, Gent M.
    Can Psychiatr Assoc J; 1973 Oct; 18(5):403-8. PubMed ID: 4147711
    [No Abstract] [Full Text] [Related]

  • 24. Measuring the pharmacological action of imipramine in the treatment of depressions.
    Rosenblatt S, Chanley JD.
    Arch Gen Psychiatry; 1974 Apr; 30(4):456-60. PubMed ID: 4815551
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Outpatient treatment of neurotic depression: medication and group psychotherapy.
    Lipman RS, Covi L.
    Proc Annu Meet Am Psychopathol Assoc; 1976 Apr; (64):178-218. PubMed ID: 772673
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [A comparative study of viloxazine and imipramine (author's transl)].
    Floru L, Tegeler J.
    Pharmakopsychiatr Neuropsychopharmakol; 1979 Jul; 12(4):313-20. PubMed ID: 386389
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Proceedings: Systematic clinical studies with clomipramine in depressed psychiatric patients--III. Standard-controlled clinical trial.
    Pecknold JC, Gratton L, Ban TA, Klingner A.
    Psychopharmacol Bull; 1976 Jan; 12(1):26-7. PubMed ID: 1108079
    [No Abstract] [Full Text] [Related]

  • 36. Symptom reduction in depression after treatment with L-tryptophan or imipramine. Item analysis of Hamilton rating scale for depression.
    Lindberg D, Ahlfors UG, Dencker SJ, Fruensgaard K, Hanstén S, Jensen K, Ose E, Pihkanen TA.
    Acta Psychiatr Scand; 1979 Sep; 60(3):287-94. PubMed ID: 386715
    [Abstract] [Full Text] [Related]

  • 37. 1. Improvement criteria in drug trials with neurotic patients.
    Kellner R.
    Psychol Med; 1971 Nov; 1(5):416-25. PubMed ID: 4945831
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Measurement of drug effects in newly hospitalized depressives.
    Rockliff BW.
    Dis Nerv Syst; 1971 Aug; 32(8):532-7. PubMed ID: 4937543
    [No Abstract] [Full Text] [Related]

  • 40. Imipramine: clinical effects and pharmacokinetic variability.
    Reisby N, Gram LF, Bech P, Nagy A, Petersen GO, Ortmann J, Ibsen I, Dencker SJ, Jacobsen O, Krautwald O, Sondergaard I, Christiansen J.
    Psychopharmacology (Berl); 1977 Nov 15; 54(3):263-72. PubMed ID: 413143
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.